Company Overview

Company name: Little Green Pharma
Description: Manufacturer of cannabis products intended to make safe, reliable and cost-effective medicinal cannabis products available. The company’s medicinal cannabis preparations with differing cannabinoid profiles from different plant varieties are produced using advanced technology in accordance with the requirement of the relevant health and regulatory authorities within Australia.
Year founded: 2017
Parent company:
Industry: Healthcare | Group: Pharmaceuticals and Biotechnology | Code:
Website: www.lgpharma.com.au
Employees:
City: Crawley
State: Western Australia
Country: Australia
Region: Oceania

Financial Highlights

Start up capital raised (USD Million): 0.82
Business status: Startup
Ownership: Privately Held (backing)
Exchange:
Ticker:
Revenue (USD Million):
Gross profit (USD Million):
Net income (USD Million)
Enterprise value:
Earnings before interest, tax, depreciation and amortization (EBITDA):
Fiscal period:
Financing Status: LGC Capital (TSXV: LG) acquired a 4.99% stake in the company for AUD 1.054 million on October 12, 2017. As consideration for the shares, LGC paid AUD 432,218 and issued 5,660,000 LGC common shares to Little Green Pharmaata deemed issue price of $0.11 per share. LGC has the option to increase its interest in Little Green Pharma to a maximum of 19.03%, subject to a number of conditions, including Australian Government regulatory approvals. Subject to the issuance by Little Green Pharma of shares to various third parties.
Number of active investors:
Profile last updated: 08-Sep-2018
Last known valuation: 16.48
Last known valuation date: 12-Oct-2017